Figure 1From: Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis Short Form-36 Individual Domain Scores. Scores at Baseline and Improvement Following 16 weeks of Therapy with ETN + MTX or DMARD + MTX (Last Observation Carried Forward Analysis)Back to article page